New Funding Opportunity for GTEx Biospecimen Management

Leidos Biomedical, Inc., on behalf of NCI, seeks proposals for management of legacy biospecimens from the GTEx program. For more information please see: http://ncioa.cancer.gov/oa-internet/sbo/rqmt/allsolicit.